Pharmacokinetics-pharmacodynamics and antitumor activity of mercaptoacetamide-based histone deacetylase inhibitors
about
Mercaptoacetamide-based class II HDAC inhibitor lowers Aβ levels and improves learning and memory in a mouse model of Alzheimer's diseaseHistone deacetylase inhibitor: antineoplastic agent and radiation modulatorToxicological and metabolic considerations for histone deacetylase inhibitors.Functional Roles of Acetylated Histone Marks at Mouse Meiotic Recombination Hot Spots.Panobinostat as Pan-deacetylase Inhibitor for the Treatment of Pancreatic Cancer: Recent Progress and Future Prospects.
P2860
Pharmacokinetics-pharmacodynamics and antitumor activity of mercaptoacetamide-based histone deacetylase inhibitors
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pharmacokinetics-pharmacodynam ...... histone deacetylase inhibitors
@en
Pharmacokinetics-pharmacodynam ...... istone deacetylase inhibitors.
@nl
type
label
Pharmacokinetics-pharmacodynam ...... histone deacetylase inhibitors
@en
Pharmacokinetics-pharmacodynam ...... istone deacetylase inhibitors.
@nl
prefLabel
Pharmacokinetics-pharmacodynam ...... histone deacetylase inhibitors
@en
Pharmacokinetics-pharmacodynam ...... istone deacetylase inhibitors.
@nl
P2093
P2860
P1476
Pharmacokinetics-pharmacodynam ...... histone deacetylase inhibitors
@en
P2093
Alfredo Velena
Zacharoula Konsoula
P2860
P304
P356
10.1158/1535-7163.MCT-09-0629
P577
2009-09-29T00:00:00Z